Casadevall said new monoclonal antibody drugs are still worth pursuing, since they have proven safe and effective against Covid. “I would not give up on something like this," he said.

In late November, the Food and Drug Administration revoked its emergency use authorization for bebtelovimab, a monoclonal antibody treatment for Covid-19, because it wasn’t effective against the ...

This was the last monoclonal antibody drug authorized by the FDA to treat COVID-19. The decision was made because it is not expected to neutralize new Omicron subvariants.

Monoclonal antibody drugs were the first tailor-made covid-19 treatment out of the gate, highly effective medicines that helped buy time before vaccines could be widely deployed.

Researchers from the Netherlands and Japan have developed antibodies for the novel coronavirus that can neutralize the pathogen in labs. The drugs still need to prove their effectiveness in human ...

In a detail-thin announcement, Amgen said that adding bemarituzumab to chemotherapy improved overall survival, though ...